Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autofluorescence and ICG in Total Thyroidectomy
NCT05117853Phase 3Recruiting
- Sponsor
- OLV Hospital
- Start
- Nov 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of indocyanine green in hypocalcemia (2 arms), sponsored by OLV Hospital. Primary endpoint: Postoperative hypocalcemia at 1 week. Started Nov 2021; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
hypocalcemia
Beyond the preview
Go deeper on NCT05117853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05117853.